Recent Blog Posts

View Post: A drug for type 2 diabetes may have safety issues, according to ...
4 Dec 2009 by NHS Choices  
First generation sulphonylureas; Second generation sulphonylureas (newer members of this drug class); Thiazolidinediones (rosiglitazone and pioglitazone); Metformin. People who were not taking any diabetes drugs were not included in the ...
View Blog: Health News from NHS Choices - http://www.nhs.uk/News/Pages/NewsArticles.aspx

---

View Post: News - Diabetes Drugs Go Head-to-Head in Study - Veria.com
4 Dec 2009
Individuals taking Actos had a 31 to 39 percent lower risk of dying compared with people taking metformin. Meanwhile, people taking Avandia (rosiglitazone) had a 34 to 41 percent higher risk of dying than people taking its cousin, ...
View Blog: Veria - http://www.veria.com/

---

View Post: Sulfonylurea, thiazolidinedione risks vs metformin British cohort ...
4 Dec 2009
"Our findings suggest a relatively unfavorable risk profile of sulfonylureas compared with metformin. This is consistent with the recommendations of the American Diabetes Association and International Diabetes Federation, which favor metformin as ... Takeda Pharmaceuticals) compared with metformin and, in separate analyses, compared with rosiglitazone (Avandia, GlaxoSmithKline)—although the latter finding's significance faded in a more fully adjusted statistical model. ...
View Blog: theHeart.org - http://www.theheart.org/

---

View Post: Aroostook Mental Health Services, Inc. - Depression: Major ...
4 Dec 2009
Sulfonylureas, long a mainstay of diabetes treatment, performed less well than metformin in a study of oral anti-diabetes drugs, but doctors said the findings aren't necessarily a reason to discontinue taking them. ... 4 issue of BMJ, also found that the diabetes medications Actos (pioglitazone) and Avandia (rosiglitazone) did not seem to raise the risk of heart attack. But Actos was associated with a lower risk of dying than Avandia, indicating Actos might be the ...
View Blog: Aroostook Mental Health Services, Inc. News - http://www.amhc.org/

---

View Post: Diabetes Drugs Go Head-to-Head in Study - Health News - Health.com
4 Dec 2009 by timeinctemp  
A class of drugs still taken by millions of people with type 2 diabetes is associated with a higher risk of dying and heart failure than the newer treatment metformin, researchers say. ... 4 issue of BMJ, also found that the diabetes medications Actos (pioglitazone) and Avandia (rosiglitazone) did not seem to raise the risk of heart attack. But Actos was associated with a lower risk of dying than Avandia, indicating Actos might be the preferred choice. ...
View Blog: Health News - http://news.health.com/

---

View Post: Rosiglitazone (Avandia) and rosiglitazone with metformin ...
29 Jan 2009
This page contains additional content about the article Rosiglitazone (Avandia) and rosiglitazone with metformin (Avandamet) for type 2 diabetes mellitus, first published in NPS RADAR in April 2004, and last updated in December 2008. ...
View Blog: Everything new at NPS - http://www.nps.org.au/home

---

View Post: Study Compares Cardiac, Death Risks of Diabetes Drugs - Depression ...
4 Dec 2009
In the thiazolidinedione class, pioglitazone had a 31 to 39 percent lower risk of all-cause mortality compared to metformin, while rosiglitazone had a 34 to 41 percent higher risk of all-cause mortality compared with pioglitazone. ...
View Blog: El Paso MHMR News - http://info.epmhmr.org/

---

View Post: dave.md: Results from the ADOPT Study
4 Dec 2006
In recently-diagnosed type 2 diabetes, initial monotherapy with rosiglitazone (Avandia® , GlaxoSmithKline) is associated with a significantly slower progression of monotherapy failure compared to metformin (Glucophage®, Bristol-Myers ...
View Blog: dave.md: Diabetes And Vascular Education:... - http://dave.md/

---

View Post: My Pure Diet. Health News & Supplements.
16 hours ago by Diet_Guru  
Sulfonylureas, the first family of oral drugs used for treating type 2 diabetes, increase the risk of death from all causes by as much as 61% compared with the newer drug metformin, British researchers have found. ... The thiazolidinediones rosiglitazone (Avandia) and pioglitazone (Actos) were not associated with an increased risk of heart attacks. Actos was associated with a 31% to 39% decrease in risk of all-cause mortality compared with metformin. ...
View Blog: My Pure Diet-Entertaining Health News n Stuff - http://mypurediet.com/

---

View Post: Effects of rosiglitazone and metformin treatment on apelin ...
8 Oct 2009 by Nikolaos PE Kadoglou, Hercules Tsanikidis,...  
We aimed to assess the differential effects of either rosiglitazone or metformin monotherapy on the aforementioned adipocytokines in patients with type 2 diabetes mellitus (T2DM). One hundred T2DM patients (30 men, 70 women), ...
View Blog: Metabolism - Clinical and Experimental... - http://www.metabolismjournal.com/inpress?rss=yes

---